• Newsletter
  • Search
  • Contacto
  • Home (next newsletter)
  • Home
  • News # 80 | Jun. 2018
  • News # 81 | Jul. 2018
  • News # 82 | Set. 2018
  • News # 83 | Oct. 2018
  • News # 84 | Nov. 2018
  • News # 85 | Dec. 2018
  • News # 86 | Jan. 2019
  • News # 87 | Feb. 2019
  • News # 88 | Mar. 2019
  • News # 89 | Apr. 2019
  • News # 90 | May. 2019
  • News # 91 | Jun. 2019
  • News # 92 | Jul. 2019
  • News # 93 | sep. 2019
  • Newsletters
    • 2008 – 2009
      • News # 1 | nov. 2008
      • News # 10 | nov/dez. 2009
      • News # 2 | dec. 2008
      • News # 3 | jan/fev. 2009
      • News # 4 | mar. 2009
      • News # 5 | abr. 2009
      • News # 6 | mai/jun. 2009
      • News # 7 | jul. 2009
      • News # 8 | ago/set. 2009
      • News # 9 | out. 2009
    • 2010 – 2011
      • News # 11 | jan/fev. 2010
      • News # 12 | mar. 2010
      • News # 13 | abr. 2010
      • News # 14 | mai. 2010
      • News # 15 | jun/jul. 2010
      • News # 16 | ago/set. 2010
      • News # 17 | out/nov. 2010
      • News # 18 | dez. 2010
      • News # 19 | jan/fev. 2011
      • News # 20 | mar/abr. 2011
      • News # 21 | mai/jun. 2011
      • News # 22 | jul/ago. 2011
      • News # 23 | set/out. 2011
      • News # 24 | nov/dez. 2011
    • 2012 – 2013
      • News # 25 | jan. 2012
      • News # 26 | fev/mar. 2012
      • News # 27 | jun. 2012
      • News # 28 | ago. 2012
      • News # 29 | set/out. 2012
      • News # 30 | nov/dez. 2012
      • News # 31 | jan. 2013
      • News # 32 | mar. 2013
      • News # 33 | abr. 2013
      • News # 34 | mai. 2013
      • News # 35 | jun. 2013
      • News # 36 | set. 2013
      •  News # 37 | out. 2013
      • News # 38 | nov/dez. 2013
    • 2014 – 2015
      • News # 39 | jan/fev. 2014
      • News # 40 | mar. 2014
      • News # 41 | abr/mai. 2014
      • News # 42 | jun/jul. 2014
      • News # 43 | set. 2014
      • News # 44 | out/nov. 2014
      • News # 45 | dez. 2014
      • News # 46 | jan. 2015
      • News # 47 | fev. 2015
      • News # 48 | abr. 2015
      • News # 49 | mai. 2015
      • News # 50 | jun. 2015
      • News # 51 | set. 2015
      • News # 52 | out. 2015
      • News # 53 | dez. 2015
    • 2016 – 2017
      • News # 54 | jan. 2016
      • News # 55 | fev. 2016
      • News # 56 | mar. 2016
      • News # 57 | abr. 2016
      • News nº 58 | may 2016
      • News # 59 | jun. 2016
      • News # 60 | jul. 2016
      • News # 61 | set. 2016
      • News # 62 | out. 2016
      • News # 63 | nov/dez. 2016
      • News # 64 | jan. 2017
      • News # 65 | fev. 2017
      • News # 66 | mar. 2017
      • News # 67 | apr. 2017
      • News # 68 | may 2017
      • News # 69 | jun. 2017
      • News # 70 | jul. 2017
      • News # 71 | set. 2017
      • News # 72 | out. 2017
      • News # 73 | nov. 2017
      • News # 74 | dez. 2017
    • 2018
      • News # 75 | jan. 2018
      • News # 76 | fev. 2018
      • News # 77 | mar. 2018
      • News # 78 | abr. 2018
      • News #79 | May 2018
  • Subscribe Newsletter
My Company
  • Home
  • Newsletters
    • 2018 – 2019
      • News nº 92 | jul. 2019
      • News nº 91 | jun. 2019
      • News nº 90 | Mai. 2019
      • News nº 89 | Abr. 2019
      • News nº 88 | Mar. 2019
      • News nº 87 | Fev. 2019
      • News nº 86 | Jan. 2019
      • News nº 85 | Dez. 2018
      • News nº 84 | Nov. 2018
      • News nº 83 | Out. 2018
      • News nº 82 | Set. 2018
      • News nº 81 | Jul. 2018
      • News nº 80 | Jun. 2018
      • News Nº 79 | Mai. 2018
      • News nº 78 | abr. 2018
      • News nº 77 | mar. 2018
      • News nº 76 | fev. 2018
      • News nº 75 | jan. 2018
    • 2016 – 2017
      • News nº 74 | dez. 2017
      • News # 73 | nov. 2017
      • News # 72 | out. 2017
      • News # 70 | set. 2017
      • News nº 70 | jul. 2017
      • News nº 69 | jun. 2017
      • News nº 68 | mai. 2017
      • News nº 67 | abr. 2017
      • News nº 66 | mar. 2017
      • News nº 65 | fev. 2017
      • News nº 64 | jan. 2017
      • News nº 63 | nov/dez. 2016
      • News nº 62 | out. 2016
      • News nº 61 | set. 2016
      • News nº 60 | jul. 2016
      • News nº 59 | jun. 2016
      • News nº 58 | mai. 2016
      • News nº 57 | abr. 2016
      • News nº 56 | mar. 2016
      • News nº 55 | fev. 2016
      • News nº 54 | jan. 2016
    • 2014 – 2015
      • News nº 53 | dez. 2015
      • News nº 52 | out. 2015
      • News nº 51 | set. 2015
      • News nº 50 | jun. 2015
      • News nº 49 | mai. 2015
      • News nº 48 | abr. 2015
      • News nº 47 | fev. 2015
      • News nº 46 | jan. 2015
      • News nº 45 | dez. 2014
      • News nº 44 | out/nov. 2014
      • News nº 43 | set. 2014
      • News nº 42 | jun/jul. 2014
      • News nº 41 | abr/mai. 2014
      • News nº 40 | mar. 2014
      • News nº 39 | jan/fev. 2014
    • 2012 – 2013
      • News nº 38 | nov/dez. 2013
      • News nº 37 | out. 2013
      • News nº 36 | set. 2013
      • News nº 35 | jun. 2013
      • News nº 34 | mai. 2013
      • News nº 33 | abr. 2013
      • News nº 32 | mar. 2013
      • News nº 31 | jan. 2013
      • News nº 30 | nov/dez. 2012
      • News nº 29 | set/out. 2012
      • News nº 28 | ago. 2012
      • News nº 27 | jun. 2012
      • News nº 26 | fev/mar. 2012
      • News nº 25 | jan. 2012
    • 2010 – 2011
      • News nº 24 | nov/dez. 2011
      • News nº 23 | set/out. 2011
      • News nº 22 | jul/ago. 2011
      • News nº 21 | mai/jun. 2011
      • News nº 20 | mar/abr. 2011
      • News nº 19 | jan/fev. 2011
      • News nº 18 | dez. 2010
      • News nº 17 | out/nov. 2010
      • News nº 16 | ago/set. 2010
      • News nº 15 | jun/jul. 2010
      • News nº 14 | mai. 2010
      • News nº 13 | abr. 2010
      • News nº 12 | mar. 2010
      • News nº 11 | jan/fev. 2010
    • 2008 – 2009
      • News nº 10 | nov/dez. 2009
      • News nº 9 | out. 2009
      • News nº 8 | ago/set. 2009
      • News nº 7 | jul. 2009
      • News nº 6 | mai/jun. 2009
      • News nº 5 | abr. 2009
      • News nº 4 | mar. 2009
      • News nº 3 | jan/fev. 2009
      • News nº 2 | dez. 2008
      • News nº 1 | nov. 2008
  • Subscrever Newsletter
  • Contacto
Main Menu
  • Home
  • Newsletters
    • 2018 – 2019
      • News nº 92 | jul. 2019
      • News nº 91 | jun. 2019
      • News nº 90 | Mai. 2019
      • News nº 89 | Abr. 2019
      • News nº 88 | Mar. 2019
      • News nº 87 | Fev. 2019
      • News nº 86 | Jan. 2019
      • News nº 85 | Dez. 2018
      • News nº 84 | Nov. 2018
      • News nº 83 | Out. 2018
      • News nº 82 | Set. 2018
      • News nº 81 | Jul. 2018
      • News nº 80 | Jun. 2018
      • News Nº 79 | Mai. 2018
      • News nº 78 | abr. 2018
      • News nº 77 | mar. 2018
      • News nº 76 | fev. 2018
      • News nº 75 | jan. 2018
    • 2016 – 2017
      • News nº 74 | dez. 2017
      • News # 73 | nov. 2017
      • News # 72 | out. 2017
      • News # 70 | set. 2017
      • News nº 70 | jul. 2017
      • News nº 69 | jun. 2017
      • News nº 68 | mai. 2017
      • News nº 67 | abr. 2017
      • News nº 66 | mar. 2017
      • News nº 65 | fev. 2017
      • News nº 64 | jan. 2017
      • News nº 63 | nov/dez. 2016
      • News nº 62 | out. 2016
      • News nº 61 | set. 2016
      • News nº 60 | jul. 2016
      • News nº 59 | jun. 2016
      • News nº 58 | mai. 2016
      • News nº 57 | abr. 2016
      • News nº 56 | mar. 2016
      • News nº 55 | fev. 2016
      • News nº 54 | jan. 2016
    • 2014 – 2015
      • News nº 53 | dez. 2015
      • News nº 52 | out. 2015
      • News nº 51 | set. 2015
      • News nº 50 | jun. 2015
      • News nº 49 | mai. 2015
      • News nº 48 | abr. 2015
      • News nº 47 | fev. 2015
      • News nº 46 | jan. 2015
      • News nº 45 | dez. 2014
      • News nº 44 | out/nov. 2014
      • News nº 43 | set. 2014
      • News nº 42 | jun/jul. 2014
      • News nº 41 | abr/mai. 2014
      • News nº 40 | mar. 2014
      • News nº 39 | jan/fev. 2014
    • 2012 – 2013
      • News nº 38 | nov/dez. 2013
      • News nº 37 | out. 2013
      • News nº 36 | set. 2013
      • News nº 35 | jun. 2013
      • News nº 34 | mai. 2013
      • News nº 33 | abr. 2013
      • News nº 32 | mar. 2013
      • News nº 31 | jan. 2013
      • News nº 30 | nov/dez. 2012
      • News nº 29 | set/out. 2012
      • News nº 28 | ago. 2012
      • News nº 27 | jun. 2012
      • News nº 26 | fev/mar. 2012
      • News nº 25 | jan. 2012
    • 2010 – 2011
      • News nº 24 | nov/dez. 2011
      • News nº 23 | set/out. 2011
      • News nº 22 | jul/ago. 2011
      • News nº 21 | mai/jun. 2011
      • News nº 20 | mar/abr. 2011
      • News nº 19 | jan/fev. 2011
      • News nº 18 | dez. 2010
      • News nº 17 | out/nov. 2010
      • News nº 16 | ago/set. 2010
      • News nº 15 | jun/jul. 2010
      • News nº 14 | mai. 2010
      • News nº 13 | abr. 2010
      • News nº 12 | mar. 2010
      • News nº 11 | jan/fev. 2010
    • 2008 – 2009
      • News nº 10 | nov/dez. 2009
      • News nº 9 | out. 2009
      • News nº 8 | ago/set. 2009
      • News nº 7 | jul. 2009
      • News nº 6 | mai/jun. 2009
      • News nº 5 | abr. 2009
      • News nº 4 | mar. 2009
      • News nº 3 | jan/fev. 2009
      • News nº 2 | dez. 2008
      • News nº 1 | nov. 2008
  • Subscrever Newsletter
  • Contacto

East and West hand in hand in the name of Science – report by Bruno Silva Santos

By Cristina Bastos On 25 January, 2019 2019 | Research and Advanced Education Comments Off on East and West hand in hand in the name of Science – report by Bruno Silva Santos Tags: slider

Six Group leaders of the iMM visited the University of Guangzhou’s Jinan (Guangzhou, China), invited by Zhinan Yin, Professor and Researcher of Immunology. Besides attending a Conference, the meeting also served to establish programs of academic cooperation between teams and future projects.

This meeting in the East followed a visit by the Chinese host Zhinan Yin and the rector of the University of Jinan last year. After visiting several European countries searching for partners for academical cooperation they came to the iMM.

Specialised in Immunology, just like Bruno Silva Santos, Zhinan Yin, he decided to contact him and challenge the Chinese officials to visit the iMM, the professional home of the Portuguese researcher. The challenge was clear, reaching an agreement between institutions in Portugal and China. The wish came true after the first visit to the iMM, and the invitation to visit China came immediately afterwards. “We really wanted to visit our scientific colleagues from China, we took 6 group leaders from the iMM to the Institute of Biomedicine and we met their elite scientists, represented by 11 group leaders. For two days we listened to each other and we had a brainstorm about how our collaboration could work”.

And there is good news for this group of scientists, because the Chinese government wants to invest in Science, trying to internationalise it, contradicting years of closed policies for a more global world. Another advantage is that Guangzhou’s Jinan has always been the Chinese university more open to the Western world. Established 112 years ago, this university was created with the aim of receiving Chinese students coming from foreign countries or from former non-Chinese colonies. With close connections to the government, Guangzhou’s Jinan can ask for funding directly and suggest budgets in accordance with its researches. As Chinese institutions are mostly focused on cancer and immunology, the connections to Portugal and the iMM became obvious, excluding, however, areas like neurology which exist only in the iMM. “Of the 32 laboratories in the iMM, I would say that 20 could participate in projects with China”.

Bruno Silva Santos and Luis Graça, from Immunology; João Barata, from Leukaemia; Carmo Fonseca, from Molecular Biology, together with Sérgio de Almeida and Sérgio Dias also connected to the area of Cancer, were the 6 researchers, also Professors at the FMUL, chosen for the first official meeting.

But it is clear that these were only first steps of a far bigger movement.

It is inevitable to ask you if Science is a global concept or if it is still somewhat divided between the reality of the West and that of the East.

Bruno Silva Santos: We can find differences in small things. Even in research projects, the Chinese researches have a great interest in Traditional Chinese Medicine, and they try to give a scientific base to what is scientific in Traditional Chinese Medicine. In other words, they test many compounds and come to the conclusion that some don’t have a scientific base, like Homoeopathy, but others do, like Acupuncture and they manage to explain the biological mechanism creating a bridge between Traditional and conventional Medicine.

And, as European scientists, does this approach make sense to you?

Bruno Silva Santos: Yes, it does, and it is feasible, as long as it is well controlled and done with scientific methods and that is what we found. But there is always another, more “eccentric” element. They find it very interesting to compare Eastern and Western diets, because there is the notion that internationalisation led China to follow bad Western eating habits. So, they carried out a study about the effects of Coca-Cola and Pepsi, with and without sugar, with and without caffeine, and they associated it with the development of multiple sclerosis in mice. With this study in mice they came to the conclusion that the sugar in Coca-Cola promotes the development of multiple sclerosis, increasing the severity of the disease. On the other hand, caffeine is a protector. Now, this study goes in the direction of one that had already been presented by Luisa Lopes, researcher in the iMM and Faculty Professor, which showed that caffeine protects against neurodegeneration. But sugar as a protector against the severity of this autoimmune disease, multiple sclerosis, was something they found interesting in this paradox between East and West. It is interesting because in the West we don’t look that much at the East.

Is it that by “absorbing” some characteristics of the East we are also opening a new horizon and perspective of Science itself?

Bruno Silva Santos: I think so, and I think that we will pay more attention to more researches. Now, of course it is necessary to separate “the wheat from the chaff”. But there is no doubt that we are missing out on important things. There are things we are testing in the West, in particular here in the iMM, and China can open doors to new therapeutic combinations. I will give you an example, today we are a lot more interested in understanding microbiome, in other words, our gut bacteria. It is important to understand how these bacteria condition many different diseases, not only the most obvious ones, but also some that lead to autism. And given the fact that China has a microbiome that is very different from ours, not only geographical but also in terms of food, leads our animal models’ mice have very different bacteria. That allows us to compare results from the disease model in a colony of mice established in the iMM and another established in Guangzhou to see if we have the same effect or not. No doubt that it can have a huge impact on our interpretation of the model, due to the fact that we are using a mouse with a different microbiome as a starting point. These Chinese scientists have already sent us a list with all the colonies of mutant mice and disease models they have, some of the models we don’t even have. So, in the context of our collaboration, we bring mice models from China to Portugal so we can test the disease models we are interested in. And this will allow another thing, in the case of models they are already using there, which is comparing results and checking whether there are any differences.

What will be the next step of this encounter between two worlds?

Bruno Silva Santos: Now I will have the responsibility of receiving a delegation from the Chinese institute later this year. The goal is to do a follow up with presentations of the iMM. As I said, it was only 6 of us, but 14 more can enter, in terms of groups. The idea is to gather everyone in the Arrábida Convent, a place to which, thanks to the Orient Foundation, one of the founders of the iMM, we have privileged access. We have already held several retreats there and we will try to hold this meeting there too. But until then we have work to do, using mice, we will exchange views and ideas about individual projects.

I can confirm that the next conference will be crucial to define this collaboration more consistently.

But there is more, in China they are investing a lot in post-doctoral training, with scholarship, making much bigger investments than Europe. And at this Chinese institute they are very interested in sharing their post-doctoral scientists. This would allow a real possibility of an exchange, with funding already guaranteed by the Chinese state. It is just necessary to agree on a rationale for the project that benefits both parts.

Let’s talk numbers to explain the dimension of things a bit better. While the congress of the Portuguese Society of Immunology brings together 300 people, the congress in China reaches 3 000 participants. Even so, the Portuguese to Chinese proportion shows the quality of what is done in our country.

While Guangzhou has 12 million inhabitants, Portugal doesn’t even reach 11 million. And as for education, there is a lot more to show. In total, China has approximately 600 universities. With 216 research institutions, 74 PhD programs, and 189 master’s degree programs, 37 different schools and 19 associated hospitals, the University of Guangzhou’s Jinan is distributed across 5 different campuses, with more than 100 thousand students and 2 200 professors. Within this framework, there are also 10 programmes taught in English, one of which is Clinical Medicine, opening the doors to internationalisation.

Researcher Zhinan Yin alone receives, in gross figures, 10 times more than what Bruno Silva Santos could have access to in Portugal.

And while China is the second world power, Portugal doesn’t compete for that ranking, but as far as for the Portuguese researcher and Professor is concerned, he is certainly ranked as one of the most internationally recognized. It was not in vain that, at the closing of the 1st Conference in Guangzhou, Zhinan Yin said that this elite Portuguese team would serve as an inspiration to raise the level of Chinese Science.

The 1st Conference in Guangzhou marks the beginning of new bridges between worlds, but now it is important to assess how European and Chinese investments are mobilized in order to put will into practice. In the name of Science. In the name of a single world.

Joana Sousa

Editorial Team

Share

Search

Index – News # 86 | jan. 2019
 Beginnings that mark the start or point to the end
 New Year, New Challenges – 2019 FMUL Activity Plan
 FMUL positions itself as one of the founders of the Collaborative Laboratory
 Diogo Ayres de Campos – Two major beginnings
 Mamede de Carvalho – good humour at the service of life
 “New Year’s lunch with the staff of @medicina_lisboa”
 Professor Fausto J. Pinto recognised by the American College of Cardiology with the International Service Award 2019
 New Frontiers in Cardiology – Focus on CTO
 FMUL Celebrates Research Day
 Professora Isabel Pavão Martins lidera discussão no Live Broadcast Migraine Science Day 2.0
 Featured Topics…Hepatitis C
 Featured Topics…HIV – Ageing and Comorbidities [Module 2]
 Promotion of Healthy Lifestyles in an Educational Context – A synergy between local authorities and the academic community
 Mentoring 2.0
 Bruno Silva Santos on the CRISPR technique
 Bruno Silva Santos knows the secret of the Delta Gamma T cells
 GAPIC Alumni, a Growing Network
 East and West hand in hand in the name of Science – report by Bruno Silva Santos
 Publicações Científicas (FMUL/HSM/IMM) dezembro 2018 – janeiro 2019
 FMUL medical students can now study in Rio de Janeiro
 Research Day through the students’ eyes
 School of Viral Hepatitis – Talking about the Liver
 Obstetrics and Gynaecology Department of the Santa Maria Hospital
 Domenico Vandelli’s Dictionary of Natural History
 Job Talks – à conversa com
 Tools For Innovation in Health – Come and break some new ground with us!
 Mova-se por Amor
 Não falte à inauguração da Aula Magna
 E se estivesse ao seu alcance salvar a vida de alguém?
 Novas Fronteiras da Cardiologia
 Falecimento Dr. Luís Filipe Diniz Cabral Caldeira
My Company

100 AnosPropriedade e Edição: Faculdade de Medicina da Universidade de Lisboa NIPC: 502662875  Periodicidade: Mensal  Diretor: Prof. Doutor Fausto J. Pinto Conselho Editorial: Prof. Doutor Fausto J. Pinto, Profª. Doutora Ana Sebastião, Prof. Doutor Mamede de Carvalho, Prof. Doutor António Vaz Carneiro, Prof. Doutor Miguel Castanho, Dr. Luís Pereira  Equipa Editorial:  Ana Raquel Moreira, Cristina Bastos, Isabel Varela, Joana Sousa, Maria de Lurdes Barata, Rui Gomes, Sónia Teixeira  Colaboração:  Gabinete de Relações Públicas, Internacionais e Comunicação  Versão Inglesa: AP|PORTUGAL- Language Services  Conceção: Metatexto, Lda. e-mail: news@medicina.ulisboa.pt  Sede do Editor e Sede da Redação: Avenida Prof. Egas Moniz, 1649-028 Lisboa Estatuto Editorial Anotado na ERC 

  • Increase Font
  • Decrease Font
  • Black & White
  • Inverse Colors
  • Highlight Links
  • Regular Font
  • Reset
Real Accessability